Department of Urology, Southern General Hospital, Glasgow.

This email address is being protected from spam bots, you need Javascript enabled to view it

To assess the efficacy of intravesical botulinum toxin type A (BTX-A) in interstitial cystitis (IC).

Eleven patients with IC were injected with BTX-A. Primary outcome measures were: Bristol Female Lower Urinary Tract Symptom Score, Kings Health Questionnaire and 24-hour frequency-volume chart. They had urodynamics done before and six weeks after injection. Detrusor contractility was assessed using the modified PIP1 (projected isovolumetric detrusor pressure).

Written by
Ramsay AK, Small DR, Conn IG.

Reference
Surgeon. 2007 Dec;5(6):331-3

PubMed Abstract
PMID:18080606

UroToday.com Painful Bladder Syndrome Section

Please log-in or register in order to submit comments.

Powered by AkoComment!